| Document Date: 2014-08-10 22:18:44
Open Document File Size: 1,05 MBShare Result on Facebook
City Perth / / Company Pfizer / MedImmune / Australian Stock Exchange / Fox Chase / PHYLOGICA LIMITED / Janssen / Roche / / Continent Europe / / Country Japan / United States / Australia / / Currency USD / / Facility Fox Chase Cancer Centre / Telethon Institute / / IndustryTerm pharmaceutical industry / manufacturing / chemical / pharmaceutical industry pipelines / / MedicalCondition previously intractable disease / cancer / burn / disease / extracellular disease / stroke / heart disease / traumatic brain injury / diseases / intracellular disease / infectious diseases / / Organization Fox Chase Cancer Centre / Australian Government / Telethon Institute for Child Health Research / / / Position leading player / / ProvinceOrState Western Australia / / Region Western Australia / / Technology drug discovery / antibodies / / URL www.phylogica.com / /
SocialTag |
BIOMEDICAL INNOVATION Confirming the selectivity of Phylomer® candidates against a disease target PHYLOGICA LIMITED